(Circulation. 1995;92:2036-2040.)
© 1995 American Heart Association, Inc.
Articles |
Identification and Molecular Analysis of Two ApoB Gene Mutations Causing Low Plasma Cholesterol Levels
From the Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Mass (F.K.W., J.O., E.J.S.); the Framingham (Mass) Heart Study (P.W.F.W); and the Gladstone Institute of Cardiovascular Disease, San Francisco, and the Cardiovascular Research Institute and the Department of Medicine, University of California, San Francisco (S.G.Y.).
Correspondence to Francine K. Welty, MD, PhD, Kennedy Hall 5th Floor, 1 Autumn St, Boston, MA 02215.
Background Familial hypobetalipoproteinemia (FHB) is an autosomal codominant disorder characterized by abnormally low plasma levels of apoB and LDL cholesterol. Heterozygotes for FHB almost always have plasma LDL cholesterol levels <70 mg/dL and are asymptomatic. Because the low cholesterol levels may protect FHB heterozygotes from coronary heart disease, the mechanisms for FHB are of considerable interest.
Methods and Results The plasma lipoproteins of 29 subjects with LDL cholesterol levels <70 mg/dL were examined by SDS-PAGE. One subject who had virtually undetectable levels of LDL cholesterol had a truncated apoB, apoB-44.4, in his lipoproteins; a second subject with an LDL cholesterol level of 44 mg/dL had apoB-55 in his lipoproteins. The apoB-44.4 (2014 amino acids in length) resulted from a frameshift caused by an 11-bp insertion in exon 26 of the apoB gene; the apoB-55 (2494 amino acids) was caused by a nonsense mutation in exon 26 of the apoB gene. The apoB-55 mutation occurred at a CpG dinucleotide pair, a mutational hot spot, and was identical to a mutation described previously in a subject with hypobetalipoproteinemia. Our subject with apoB-55, however, had a different haplotype than the subject described previously, suggesting that the two apoB-55 mutations may have arisen independently. Of note, the apoB-55 proband's father, who had very low cholesterol levels and who probably carried the apoB-55 mutation, had significant coronary and aortic atherosclerosis at autopsy.
Conclusions In a study of adults with low LDL cholesterol levels, we discovered two subjects with truncated apoB proteins and identified the responsible mutations. ApoB gene mutations causing truncated apoB are not particularly rare in subjects with low cholesterol levels. The role of these mutations in preventing atherosclerosis deserves further study.
Key Words: molecular biology • lipoproteins • apolipoproteins • arteriosclerosis • cholesterol
This article has been cited by other articles:
 |
|
 |
|
  J. C. Cohen, E. Boerwinkle, T. H. Mosley Jr., and H. H. Hobbs Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med., March 23, 2006; 354(12): 1264 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Xu, W. J. Brecht, K. H. Weisgraber, R. W. Mahley, and Y. Huang Apolipoprotein E4 Domain Interaction Occurs in Living Neuronal Cells as Determined by Fluorescence Resonance Energy Transfer J. Biol. Chem., June 11, 2004; 279(24): 25511 - 25516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schonfeld Familial hypobetalipoproteinemia: a review J. Lipid Res., May 1, 2003; 44(5): 878 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schonfeld, B. W. Patterson, D. A. Yablonskiy, T. S. K. Tanoli, M. Averna, N. Elias, P. Yue, and J. Ackerman Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis J. Lipid Res., March 1, 2003; 44(3): 470 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. K. Welty, K. A. Guida, and J. J. Andersen Donor Splice-Site Mutation (210+1G_C) in the ApoB Gene Causes a Very Low Level of ApoB-100 and LDL Cholesterol Arterioscler Thromb Vasc Biol, November 1, 2001; 21(11): 1864 - 1865. [Full Text] [PDF]
|
|
|
|
|
|
P. Tarugi, A. Lonardo, C. Gabelli, F. Sala, G. Ballarini, I. Cortella, L. Previato, S. Bertolini, R. Cordera, and S. Calandra Phenotypic expression of familial hypobetalipoproteinemia in three kindreds with mutations of apolipoprotein B gene J. Lipid Res., October 1, 2001; 42(10): 1552 - 1561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Couture, J. D. Otvos, L. A. Cupples, P. W. F. Wilson, E. J. Schaefer, and J. M. Ordovas Association of the A-204C polymorphism in the cholesterol 7{alpha}-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study J. Lipid Res., October 1, 1999; 40(10): 1883 - 1889. [Abstract] [Full Text]
|
|
|
|
|
|
J. Wu, J. Kim, Q. Li, P.-Y. Kwok, T. G. Cole, B. Cefalu, M. Averna, and G. Schonfeld Known mutations of apoB account for only a small minority of hypobetalipoproteinemia J. Lipid Res., May 1, 1999; 40(5): 955 - 959. [Abstract] [Full Text]
|
|
|
|
|
|
F. K. Welty, C. Lahoz, K. L. Tucker, J. M. Ordovas, P. W. F. Wilson, and E. J. Schaefer Frequency of ApoB and ApoE Gene Mutations as Causes of Hypobetalipoproteinemia in the Framingham Offspring Population Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1745 - 1751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-F. Zhu, D. Noto, R. Seip, A. Shaish, and G. Schonfeld Organ Loci of Catabolism of Short Truncations of ApoB Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1032 - 1038. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. K. Welty, M. A. Mittleman, P. W.F. Wilson, P. A. Sutherland, T. H. Matheney, I. Lipinska, J. E. Muller, D. Levy, and G. H. Tofler Hypobetalipoproteinemia Is Associated With Low Levels of Hemostatic Risk Factors in the Framingham Offspring Population Circulation, February 18, 1997; 95(4): 825 - 830. [Abstract] [Full Text]
|
|